Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up

I. Nurmi-Lüthje; R. Tiihonen; E. L. Paattiniemi; H. Sarkkinen; H. Naboulsi; S. Pigg; J. P. Kaukonen; M. Kataja; P. Lüthje

doi:10.1007/s00198-021-06094-z

Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up

I. Nurmi-Lüthje, R. Tiihonen, E. L. Paattiniemi, H. Sarkkinen, H. Naboulsi, S. Pigg, J. P. Kaukonen, M. Kataja, P. Lüthje

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	Osteoporosis International
Volume	33
Pages (from-to)	611–621
Number of pages	11
ISSN	0937-941X
DOIs	https://doi.org/10.1007/s00198-021-06094-z
Publication status	Published - 2022
MoE publication type	A1 Journal article-refereed

Bibliographical note

Publisher Copyright:
© 2021, International Osteoporosis Foundation and National Osteoporosis Foundation.

Fields of Science

Hip fracture
Mortality
Prospective cohort
Serum 25-hydroxyvitamin D
Survival
MORTALITY
PREVENTION
VITAMIN-D STATUS
3121 General medicine, internal medicine and other clinical medicine

Access to Document

10.1007/s00198-021-06094-z

Cite this

Nurmi-Lüthje, I., Tiihonen, R., Paattiniemi, E. L., Sarkkinen, H., Naboulsi, H., Pigg, S., Kaukonen, J. P., Kataja, M., & Lüthje, P. (2022). Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up. Osteoporosis International, 33, 611–621. https://doi.org/10.1007/s00198-021-06094-z

@article{810e83f302c342dea345fcb7786831a8,

title = "Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up",

keywords = "Hip fracture, Mortality, Prospective cohort, Serum 25-hydroxyvitamin D, Survival, MORTALITY, PREVENTION, VITAMIN-D STATUS, 3121 General medicine, internal medicine and other clinical medicine",

author = "I. Nurmi-L{\"u}thje and R. Tiihonen and Paattiniemi, {E. L.} and H. Sarkkinen and H. Naboulsi and S. Pigg and Kaukonen, {J. P.} and M. Kataja and P. L{\"u}thje",

note = "Publisher Copyright: {\textcopyright} 2021, International Osteoporosis Foundation and National Osteoporosis Foundation.",

year = "2022",

doi = "10.1007/s00198-021-06094-z",

language = "English",

volume = "33",

pages = "611–621",

journal = "Osteoporosis International",

issn = "0937-941X",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

Nurmi-Lüthje, I, Tiihonen, R , Paattiniemi, EL , Sarkkinen, H , Naboulsi, H , Pigg, S, Kaukonen, JP, Kataja, M & Lüthje, P 2022, 'Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up', Osteoporosis International, vol. 33, pp. 611–621. https://doi.org/10.1007/s00198-021-06094-z

Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up. / Nurmi-Lüthje, I.; Tiihonen, R.; Paattiniemi, E. L. et al.
In: Osteoporosis International, Vol. 33, 2022, p. 611–621.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland

T2 - a minimum 3-year follow-up

AU - Nurmi-Lüthje, I.

AU - Tiihonen, R.

AU - Paattiniemi, E. L.

AU - Sarkkinen, H.

AU - Naboulsi, H.

AU - Pigg, S.

AU - Kaukonen, J. P.

AU - Kataja, M.

AU - Lüthje, P.

PY - 2022

Y1 - 2022

KW - Hip fracture

KW - Mortality

KW - Prospective cohort

KW - Serum 25-hydroxyvitamin D

KW - Survival

KW - MORTALITY

KW - PREVENTION

KW - VITAMIN-D STATUS

KW - 3121 General medicine, internal medicine and other clinical medicine

U2 - 10.1007/s00198-021-06094-z

DO - 10.1007/s00198-021-06094-z

M3 - Article

AN - SCOPUS:85116012384

SN - 0937-941X

VL - 33

SP - 611

EP - 621

JO - Osteoporosis International

JF - Osteoporosis International

ER -